Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics

Arai Y, Helmberger T, White S, Zech J. C. The challenge of liver tumors for interventional oncology: past, present and future - introductory editorial. Br J Radiol. 2022 Sep 1;95(1138):20229005. doi: https://doi.org/10.1259/bjr.20229005.

Xiao Y, Zheng X, Zhou C, Huang P, Wu F, Yang C, Zeng M. Combined hepatocellular carcinoma-cholangiocarcinoma with a predominant HCC component: better survival and MRI-based prediction. Eur Radiol. 2022 Sep;16. https://doi.org/10.1007/s00330-022-09131-5. Epub ahead of print.

Granata V, Fusco R, Catalano O, Avallone A, Leongito M, Izzo F, Petrillo A. Peribiliary liver metastases MR findings. Med Oncol. 2017 Jul;34(7):124. https://doi.org/10.1007/s12032-017-0981-7.

Yang Z, Zhang C, Li Z, Wu L, Li M. Comparison of Hepatectomy and Hemangiomas Stripping on Patients with Giant Hepatic Hemangiomas.Contrast Media Mol Imaging. 2022 Aug31;2022:1350826. doi: https://doi.org/10.1155/2022/1350826.

Cholangiocarcinoma Working Group. Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment. Dig Liver Dis. 2020 Dec;52(12):1430–1442. doi: https://doi.org/10.1016/j.dld.2020.08.030.

Granata V, Fusco R, Venanzio Setola S, Mattace Raso M, Avallone A, De Stefano A, Nasti G, Palaia R, Delrio P, Petrillo A, Izzo F. Liver radiologic findings of chemotherapy-induced toxicity in liver colorectal metastases patients. Eur Rev Med Pharmacol Sci. 2019 Nov;23(22):9697–706. https://doi.org/10.26355/eurrev_201911_19531.

Granata V, Fusco R, Avallone A, Cassata A, Palaia R, Delrio P, Grassi R, Tatangelo F, Grazzini G, Izzo F, Petrillo A. Abbreviated MRI protocol for colorectal liver metastases: How the radiologist could work in pre surgical setting.PLoS One. 2020 Nov19;15(11):e0241431. doi: https://doi.org/10.1371/journal.pone.0241431.

Schooler GR, Infante JC, Acord M, Alazraki A, Chavhan GB, Davis JC, Khanna G, Morani AC, Morin CE, Nguyen HN, Rees MA, Shaikh R, Srinivasan A, Squires JH, Tang E, Thacker PG, Towbin AJ. Imaging of pediatric liver tumors: a COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper. Pediatr Blood Cancer. 2022 Sep;14:e29965. https://doi.org/10.1002/pbc.29965.

Papaconstantinou D, Tsilimigras DI, Pawlik TM. Recurrent Hepatocellular Carcinoma: Patterns, Detection, Staging and Treatment.J Hepatocell Carcinoma. 2022 Sep3;9:947–957. doi: https://doi.org/10.2147/JHC.S342266.

Granata V, Fusco R, Petrillo A. Additional considerations on use of abbreviated liver MRI in patients with colorectal liver metastases. AJR Am J Roentgenol. 2021 Jul;217(1):W1. https://doi.org/10.2214/AJR.21.25652.

Granata V, Grassi R, Fusco R, Setola SV, Belli A, Ottaiano A, Nasti G, La Porta M, Danti G, Cappabianca S, Cutolo C, Petrillo A, Izzo F. Intrahepatic cholangiocarcinoma and its differential diagnosis at MRI: how radiologist should assess MR features. Radiol Med. 2021 Dec;126(12):1584–600. https://doi.org/10.1007/s11547-021-01428-7.

Granata V, Fusco R, Avallone A, Catalano O, Piccirillo M, Palaia R, Nasti G, Petrillo A, Izzo F. A radiologist’s point of view in the presurgical and intraoperative setting of colorectal liver metastases. Future Oncol. 2018 Sep;14(21):2189–206. https://doi.org/10.2217/fon-2018-0080.

Granata V, Fusco R, Catalano O, Avallone A, Palaia R, Botti G, Tatangelo F, Granata F, Cascella M, Izzo F, Petrillo A. Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases.PLoS One. 2017 Jun20;12(6):e0179951. doi: https://doi.org/10.1371/journal.pone.0179951.

Aboutaleb M, Kheirkhah N, Samani A, Sadeghi-Naini A. An Enhanced Method for Full-Inversion-Based Ultrasound Elastography of the Liver.Annu Int Conf IEEE Eng Med Biol Soc. 2022Jul;2022:3887–3890. doi: https://doi.org/10.1109/EMBC48229.2022.9871656.

Izzo F, Piccirillo M, Albino V, Palaia R, Belli A, Granata V, Setola S, Fusco R, Petrillo A, Orlando R, Tosone G, Scordino F, Curley SA. Prospective screening increases the detection of potentially curable hepatocellular carcinoma: results in 8,900 high-risk patients. HPB (Oxford). 2013 Dec;15(12):985–90. https://doi.org/10.1111/hpb.12080.

Avallone A, Pecori B, Bianco F, Aloj L, Tatangelo F, Romano C, Granata V, Marone P, Leone A, Botti G, Petrillo A, Caracò C, Iaffaioli VR, Muto P, Romano G, Comella P, Budillon A, Delrio P. Critical role of bevacizumab scheduling in combination with pre-surgical chemo-radiotherapy in MRI-defined high-risk locally advanced rectal cancer: Results of the BRANCH trial. Oncotarget. 2015 Oct 6;6(30):30394-407. doi: https://doi.org/10.18632/oncotarget.4724.

Bimonte S, Leongito M, Barbieri A, Del Vecchio V, Barbieri M, Albino V, Piccirillo M, Amore A, Di Giacomo R, Nasto A, Granata V, Petrillo A, Arra C, Izzo F. Inhibitory effect of (-)-epigallocatechin-3-gallate and bleomycin on human pancreatic cancer MiaPaca-2 cell growth.Infect Agent Cancer. 2015 Jul29;10:22. doi: https://doi.org/10.1186/s13027-015-0016-y.

Ottaiano A, Scala S, Santorsola M, Trotta AM, D’Alterio C, Portella L, Clemente O, Nappi A, Zanaletti N, De Stefano A, Avallone A, Granata V, Notariello C, Luce A, Lombardi A, Picone C, Petrillo A, Perri F, Tatangelo F, Di Mauro A, Albino V, Izzo F, Rega D, Pace U, Di Marzo M, Chiodini P, De Feo G, Del Prete P, Botti G, Delrio P, Caraglia M, Nasti G. Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol. Ther Adv Med Oncol. 2021 Mar;24:13:1758835921989223. https://doi.org/10.1177/1758835921989223.

Ottaiano A, Caraglia M, Di Mauro A, Botti G, Lombardi A, Galon J, Luce A, D’Amore L, Perri F, Santorsola M, Hermitte F, Savarese G, Tatangelo F, Granata V, Izzo F, Belli A, Scala S, Delrio P, Circelli L, Nasti G. Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer. Cancers (Basel). 2020 Oct 21;12(10):3073. doi: https://doi.org/10.3390/cancers12103073.

Izzo F, Granata V, Fusco R, D’Alessio V, Petrillo A, Lastoria S, Piccirillo M, Albino V, Belli A, Tafuto S, Avallone A, Patrone R, Palaia R. Clinical Phase I/II Study: Local Disease Control and Survival in Locally Advanced Pancreatic Cancer Treated with Electrochemotherapy. J Clin Med. 2021 Mar 22;10(6):1305. doi: https://doi.org/10.3390/jcm10061305.

Izzo F, Granata V, Fusco R, D’Alessio V, Petrillo A, Lastoria S, Piccirillo M, Albino V, Belli A, Nasti G, Avallone A, Patrone R, Grassi F, Leongito M, Palaia R. A Multicenter Randomized controlled prospective study to assess efficacy of laparoscopic Electrochemotherapy in the treatment of locally Advanced Pancreatic Cancer. J Clin Med. 2021 Sep;5(17):4011. https://doi.org/10.3390/jcm10174011.

Avallone A, Piccirillo MC, Nasti G, Rosati G, Carlomagno C, Di Gennaro E, Romano C, Tatangelo F, Granata V, Cassata A, Silvestro L, De Stefano A, Aloj L, Vicario V, Nappi A, Leone A, Bilancia D, Arenare L, Petrillo A, Lastoria S, Gallo C, Botti G, Delrio P, Izzo F, Perrone F, Budillon A. Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer: A Randomized Clinical Trial. JAMA Netw Open. 2021 Jul 1;4(7):e2118475. doi: https://doi.org/10.1001/jamanetworkopen.2021.18475.

Ottaiano A, Petito A, Santorsola M, Gigantino V, Capuozzo M, Fontanella D, Di Franco R, Borzillo V, Buonopane S, Ravo V, Scipilliti E, Totaro G, Serra M, Ametrano G, Penta R, Tatangelo F, Scognamiglio G, Di Mauro A, Di Bonito M, Napolitano M, Scala S, Rea G, Santagata S, Lombardi A, Grimaldi A, Caputo C, Crispo A, Celentano E, De Feo G, Circelli L, Savarese G, Ruggiero R, Perri F, Granata V, Botti G, Caraglia M, Nasti G, Muto P. Prospective Evaluation of Radiotherapy-Induced Immunologic and Genetic Effects in Colorectal Cancer Oligo-Metastatic Patients with Lung-Limited Disease: The PRELUDE-1 Study. Cancers (Basel). 2021 Aug 23;13(16):4236. doi: https://doi.org/10.3390/cancers13164236.

Ottaiano A, de Vera d’Aragona RP, Trotta AM, Santorsola M, Napolitano M, Scognamiglio G, Tatangelo F, Grieco P, Zappavigna S, Granata V, Perri F, Luce A, Savarese G, Ianniello M, Casillo M, Petrillo N, Belli A, Izzo F, Nasti G, Caraglia M, Scala S. Characterization of KRAS Mutational Regression in Oligometastatic Patients. Front Immunol. 2022 Jul;22:13:898561. https://doi.org/10.3389/fimmu.2022.898561.

Argalia G, Tarantino G, Ventura C, Campioni D, Tagliati C, Guardati P, Kostandini A, Marzioni M, Giuseppetti GM, Giovagnoni A. Shear wave elastography and transient elastography in HCV patients after direct-acting antivirals. Radiol Med. 2021 Jun;126(6):894–9. https://doi.org/10.1007/s11547-020-01326-4.

Giovagnoni A. A farewell from the “old” editor-in-Chief. Radiol Med. 2021 Jan;126(1):1–2. https://doi.org/10.1007/s11547-020-01325-5.

Cicero G, Mazziotti S, Silipigni S, Blandino A, Cantisani V, Pergolizzi S, D’Angelo T, Stagno A, Maimone S, Squadrito G, Ascenti G. Dual-energy CT quantification of fractional extracellular space in cirrhotic patients: comparison between early and delayed equilibrium phases and correlation with oesophageal varices. Radiol Med. 2021 Jun;126(6):761–7. https://doi.org/10.1007/s11547-021-01341-z.

Granata V, Fusco R, Setola SV, Avallone A, Palaia R, Grassi R, Izzo F, Petrillo A. Radiological assessment of secondary biliary tree lesions: an update. J Int Med Res. 2020 Jun;48(6):300060519850398. https://doi.org/10.1177/0300060519850398.

Granata V, Grassi R, Fusco R, Belli A, Palaia R, Carrafiello G, Miele V, Grassi R, Petrillo A, Izzo F. Local ablation of pancreatic tumors: State of the art and future perspectives. World J Gastroenterol. 2021 Jun 21;27(23):3413–3428. doi: https://doi.org/10.3748/wjg.v27.i23.3413.

Fusco R, Simonetti I, Ianniello S, Villanacci A, Grassi F, Dell’Aversana F, Grassi R, Cozzi D, Bicci E, Palumbo P, Borgheresi A, Giovagnoni A, Miele V, Barile A, Granata V. Pulmonary Lymphangitis Poses a Major Challenge for Radiologists in an Oncological Setting during the COVID-19 Pandemic. J Pers Med. 2022 Apr 12;12(4):624. doi: https://doi.org/10.3390/jpm12040624.

Granata V, Fusco R, Salati S, Petrillo A, Di Bernardo E, Grassi R, Palaia R, Danti G, La Porta M, Cadossi M, Gašljević G, Sersa G, Izzo F. A systematic review about imaging and histopathological findings for detecting and evaluating Electroporation based treatments response. Int J Environ Res Public Health. 2021 May;24(11):5592. https://doi.org/10.3390/ijerph18115592.

Tafuto S, von Arx C, De Divitiis C, Maura CT, Palaia R, Albino V, Fusco R, Membrini M, Petrillo A, Granata V, Izzo F, ENETS Center of Excellence Multidisciplinary Group for Neuroendocrine Tumors in Naples (Italy). Electrochemotherapy as a new approach on pancreatic cancer and on liver metastases. Int J Surg. 2015 Sep;21(Suppl 1):78–82. https://doi.org/10.1016/j.ijsu.2015.04.095.

Semaan S, Vietti Violi N, Lewis S, Chatterji M, Song C, Besa C, Babb JS, Fiel MI, Schwartz M, Thung S, Sirlin CB, Taouli B. Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid. Eur Radiol. 2020 Feb;30(2):1020–30. https://doi.org/10.1007/s00330-019-06458-4.

Lee DH, Lee JM, Baek JH, Shin CI, Han JK, Choi BI. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings. Radiology. 2015 Jan;274(1):149–60. https://doi.org/10.1148/radiol.14140141.

Granata V, Fusco R, Maio F, Avallone A, Nasti G, Palaia R, Albino V, Grassi R, Izzo F, Petrillo A. Qualitative assessment of EOB-GD-DTPA and Gd-BT-DO3A MR contrast studies in HCC patients and colorectal liver metastases.Infect Agent Cancer. 2019 Nov27;14:40. doi: https://doi.org/10.1186/s13027-019-0264-3.

Zech CJ, Ba-Ssalamah A, Berg T, Chandarana H, Chau GY, Grazioli L, Kim MJ, Lee JM, Merkle EM, Murakami T, Ricke J, Sirlin B, Song C, Taouli B, Yoshimitsu B, Koh K. Consensus report from the 8th International Forum for Liver magnetic resonance imaging. Eur Radiol. 2020 Jan;30(1):370–82. https://doi.org/10.1007/s00330-019-06369-4.

Granata V, Catalano O, Fusco R, Tatangelo F, Rega D, Nasti G, Avallone A, Piccirillo M, Izzo F, Petrillo A. The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA “uptake” on the hepatobiliary phase of MR imaging. Abdom Imaging. 2015 Oct;40(7):2364–71. https://doi.org/10.1007/s00261-015-0488-7.

Stefanini M, Simonetti G. Interventional magnetic resonance imaging suite (IMRIS): how to build and how to use. Radiol Med. 2022 Aug;26. https://doi.org/10.1007/s11547-022-01537-x.

Granata V, Fusco R, Setola SV, Castelguidone ELD, Camera L, Tafuto S, Avallone A, Belli A, Incollingo P, Palaia R, Izzo F, Petrillo A. The multidisciplinary team for gastroenteropancreatic neuroendocrine tumours: the radiologist’s challenge.Radiol Oncol. 2019 Oct25;53(4):373–387. doi: https://doi.org/10.2478/raon-2019-0040.

Nakamura Y, Higaki T, Honda Y, Tatsugami F, Tani C, Fukumoto W, Narita K, Kondo S, Akagi M, Awai K. Advanced CT techniques for assessing hepatocellular carcinoma. Radiol Med. 2021 Jul;126(7):925–35. https://doi.org/10.1007/s11547-021-01366-4.

Perl RM, Portugall J, Hinterleitner C, Hinterleitner M, Kloth C, Walter SS, Bitzer M, Horger MS. Differences Between CT-Perfusion and Biphasic Contrast-enhanced CT for Detection and Characterization of Hepatocellular Carcinoma: Potential Explanations for Discrepant Cases.Anticancer Res. 2021Mar;41(3):1451–1458. doi: https://doi.org/10.21873/anticanres.14903.

Kurucay M, Kloth C, Kaufmann S, Nikolaou K, Bösmüller H, Horger M, Thaiss WM. Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?Cancer Imaging. 2017 Jun28;17(1):18. doi: https://doi.org/10.1186/s40644-017-0121-9.

Fusco R, Setola SV, Raiano N, Granata V, Cerciello V, Pecori B, Petrillo A. Analysis of a monocentric computed tomography dosimetric database using a radiation dose index monitoring software: dose levels and alerts before and after the implementation of the adaptive statistical iterative reconstruction on CT images. Radiol Med. 2022 Jul;127(7):733–42. https://doi.org/10.1007/s11547-022-01481-w.

De Muzio F, Cutolo C, Dell’Aversana F, Grassi F, Ravo L, Ferrante M, Danti G, Flammia F, Simonetti I, Palumbo P, Bruno F, Pierpaoli L, Fusco R, Giovagnoni A, Miele V, Barile A, Granata V. Complications after Thermal Ablation of Hepatocellular Carcinoma and Liver Metastases: Imaging Findings. Diagnostics (Basel). 2022 May 5;12(5):1151. doi: https://doi.org/10.3390/diagnostics12051151.

Ierardi AM, Stellato E, Pellegrino G, Bonelli C, Cellina M, Renzulli M, Biondetti P, Carrafiello G. Fluid-dynamic control microcatheter used with glue: preliminary experience on its feasibility and safety. Radiol Med. 2022 Mar;127(3):272–6. https://doi.org/10.1007/s11547-022-01461-0.

Granata V, Fusco R, Catalano O, Filice S, Amato DM, Nasti G, Avallone A, Izzo F, Petrillo A. Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging. PLoS One. 2015 Nov 13;10(11):e0142876. doi: https://doi.org/10.1371/journal.pone.0142876.

Izzo F, Palaia R, Albino V, Amore A, di Giacomo R, Piccirillo M, Leongito M, Nasto A, Granata V, Petrillo A, Lastoria S. Hepatocellular carcinoma and liver metastases: clinical data on a new dual-lumen catheter kit for surgical sealant infusion to prevent perihepatic bleeding and dissemination of cancer cells following biopsy and loco-regional treatments.Infect Agent Cancer. 2015 Apr10;10:11. doi: https://doi.org/10.1186/s13027-015-0006-0.

Granata V, Fusco R, Setola SV, Piccirillo M, Leongito M, Palaia R, Granata F, Lastoria S, Izzo F, Petrillo A. Early radiological assessment of locally advanced pancreatic cancer treated with electrochemotherapy. World J Gastroenterol. 2017 Jul 14;23(26):4767–4778. doi: https://doi.org/10.3748/wjg.v23.i26.4767.

Granata V, Fusco R, Piccirillo M, Palaia R, Petrillo A, Lastoria S, Izzo F. Electrochemotherapy in locally advanced pancreatic cancer: preliminary results. Int J Surg. 2015 Jun;18:230–6. https://doi.org/10.1016/j.ijsu.2015.04.055.

Granata V, Fusco R, de Lutio di Castelguidone E, Avallone A, Palaia R, Delrio P, Tatangelo F, Botti G, Grassi R, Izzo F, Petrillo A. Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection. BMC Gastroenterol. 2019 Jul;24(1):129. https://doi.org/10.1186/s12876-019-1036-7.

Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal Cancer: a review. JAMA. 2021 Feb;16(7):669–85. https://doi.org/10.1001/jama.2021.0106.

Kopetz S, Chang GJ, Overman MJ, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009;27(22):3677–83.

Article  PubMed  PubMed Central  Google Scholar 

Pawlik TM, Scoggins CR, Zorzi D et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241(5):715–722, discussion 722–714.

Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist. 2008;13(1):51–64.

Article  PubMed  Google Scholar 

Aquina CT, Brown ZJ, Beane JD, Ejaz A, Cloyd JM, Tsung A, Adam MO, Pawlik TM, Kim AC. Disparities in Care Access to Liver-Directed Therapy among Medicare beneficiaries with colorectal Cancer Liver Metastasis. Ann Surg Oncol. 2022 Sep;23:1–10. https://doi.org/10.1245/s10434-022-12513-0.

Fong Y, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230(3):309–18. discussion 318 – 21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nordlinger B, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients, Association Francaise de Chirurgie. Cancer. 1996;77(7):1254–62.

Article  CAS  PubMed  Google Scholar 

Margonis GA, et al. Genetic and morphological evaluation (GAME) score for patients with colorectal liver metastases. Br J Surg. 2018;105(9):1210–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fusco R, Granata V, Rega D, Russo C, Pace U, Pecori B, Tatangelo F, Botti G, Izzo F, Cascella M, et al. Morphological and functional features prognostic factor of magnetic resonance imaging in locally advanced rectal cancer. Acta Radiol. 2018;60:815–25.

Article  PubMed  Google Scholar 

Fusco R, Petrillo M, Granata V, Filice S, Sansone M, Catalano O, Petrillo A. Magnetic resonance imaging evaluation in neoadjuvant therapy of locally advanced rectal cancer: a systematic review. Radiol Oncol. 2017;51:252–62.

Article  PubMed  PubMed Central  Google Scholar 

Van den Eynden GG, Bird NC, Majeed AW, Van Laere S, Dirix LY, Vermeulen PB. The histological growth pattern of colorectal cancer liver metastases has prognostic value. Clin Exp Metastasis. 2012;29:541–9.

Article  PubMed  Google Scholar 

Eefsen RL, Vermeulen PB, Christensen IJ, Laerum OD, Mogensen MB, Rolff HC, Van Den Eynden GG, Høyer-Hansen G, Osterlind K, Vainer B, et al. Growth pattern of colorectal liver metastasis as a marker of recurrence risk. Clin Exp Metastasis. 2015;32:369–81.

Article  CAS  PubMed  Google Scholar 

Moro CF, Bozóky B, Gerling M. Growth patterns of colorectal cancer liver metastases and their impact on prognosis: a systematic review. BMJ Open Gastroenterol. 2018;5:e000217.

Article  Google Scholar 

Chiloiro G, Cusumano D, de Franco P, Lenkowicz J, Boldrini L, Carano D, Barbaro B, Corvari B, Dinapoli N, Giraffa M, et al. Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development. Radiol Med. 2022;127:11–20.

Article  PubMed  Google Scholar 

Hof J, Kok K, Sijmons RH, De Jong KP. Systematic review of the Prognostic Role of the Immune System after surgery of Colorectal Liver Metastases. Front Oncol. 2019;9:148.

Article  PubMed  PubMed Central  Google Scholar 

Park SH, Kim YS, Choi J. Dosimetric analysis of the effects of a temporary tissue expander on the radiotherapy technique. Radiol Med. 2021 Mar;126(3):437–44. https://doi.org/10.1007/s11547-020-01297-6.

Bozkurt M, Eldem G, Bozbulut UB, Bozkurt MF, Kılıçkap S, Peynircioğlu B, Çil B, Lay Ergün E, Volkan-Salanci B. Factors affecting the response to Y-90 microsphere therapy in the cholangiocarcinoma patients. Radiol Med. 2021 Feb;126(2):323–33. https://doi.org/10.1007/s11547-020-01240-9.

Dercle L, Lu L, Schwartz LH, Qian M, Tejpar S, Eggleton P, Zhao B, Piessevaux H. Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway. J Natl Cancer Inst. 2020 Sep 1;112(9):902–912. doi: https://doi.org/10.1093/jnci/djaa017.

Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009 May;50(Suppl 1):122S–50S. https://doi.org/10.2967/jnumed.108.057307.

Spinczyk D. Measuring Respiratory Motion for Supporting the Minimally Invasive Destruction of Liver Tumors. Sensors (Basel). 2022 Aug 26;22(17):6446. doi: https://doi.org/10.3390/s22176446.

Bera K, Braman N, Gupta A, Velcheti V, Madabhushi A. Predicting cancer outcomes with radiomics and artificial intelligence in radiology. Nat Rev Clin Oncol. 2022 Feb;19(2):132–46. https://doi.org/10.1038/s41571-021-00560-7.

Taghavi M, Trebeschi S, Simões R, Meek DB, Beckers RCJ, Lambregts DMJ, Verhoef C, Houwers JB, van der Heide UA, Beets-Tan RGH, Maas M. Machine learning-based analysis of CT radiomics model for prediction of colorectal metachronous liver metastases. Abdom Radiol (NY). 2021 Jan;46(1):249–56. https://doi.org/10.1007/s00261-020-02624-1.

Granata V, de Lutio di Castelguidone E, Fusco R, Catalano O, Piccirillo M, Palaia R, Izzo F, Gallipoli AD, Petrillo A. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area. Radiol Med. 2016 Feb;121(2):122–31. https://doi.org/10.1007/s11547-015-0582-5. Epub 2015 Sep 7. PMID: 26345332.

Rocca A, Brunese MC, Santone A, Avella P, Bianco P, Scacchi A, Scaglione M, Bellifemine F, Danzi R, Varriano G, Vallone G, Calise F, Brunese L. Early diagnosis of Liver Metastases from Colorectal Cancer through CT Radiomics and formal methods: a pilot study. J Clin Med. 2021 Dec;22(1):31. https://doi.org/10.3390/jcm11010031.

Merlotti A, Bruni A, Borghetti P, Ramella S, Scotti V, Trovò M, Chiari R, Lohr F, Ricardi U, Bria E, Pappagallo GL, D’Angelillo RM, Arcangeli S. Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO). Radiol Med. 2021 Aug;126(8):1117–28. https://doi.org/10.1007/s11547-021-01362-8.

Wei J, Cheng J, Gu D, Chai F, Hong N, Wang Y, Tian J. Deep learning-based radiomics predicts response to chemotherapy in colorectal liver metastases.Med Phys. 2021 Jan;48(1):513–522. doi: https://doi.org/10.1002/mp.14563.

Dias AG, Pinto DFS, Borges MF, Pereira MH, Santos JAM, Cunha LT, Lencart J. Optimization of skin dose using in-vivo MOSFET dose measurements in bolus/non-bolus fraction ratio: a VMAT and a 3DCRT study. J Appl Clin Med Phys. 2019 Feb;20(2):63–70. https://doi.org/10.1002/acm2.12525.

Falcinelli L, Mendichi M, Chierchini S, Tenti MV, Bellavita R, Saldi S, Ingrosso G, Reggioli V, Bini V, Aristei C. Pulmonary function in stereotactic body radiotherapy with helical tomotherapy for primary and metastatic lung lesions. Radiol Med. 2021 Jan;126(1):163–9. https://doi.org/10.1007/s11547-020-01223-w.

Arslan A, Aktas E, Sengul B, Tekin B. Dosimetric evaluation of left ventricle and left anterior descending artery in left breast radiotherapy. Radiol Med. 2021 Jan;126(1):14–21. https://doi.org/10.1007/s11547-020-01201-2.

Barra S, Guarnieri A, di Monale E, Bastia MB, Marcenaro M, Tornari E, Belgioia L, Magrini SM, Ricardi U, Corvò R. Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter italian trial suggest a larger adoption in clinical practice. Radiol Med. 2021 Jan;126(1):142–6. https://doi.org/10.1007/s11547-020-01216-9.

Cellini F, Di Franco R, Manfrida S, Borzillo V, Maranzano E, Pergolizzi S, Morganti AG, Fusco V, Deodato F, Santarelli M, Arcidiacono F, Rossi R, Reina S, Merlotti A, Jereczek-Fossa BA, Tozzi A, Siepe G, Cacciola A, Russi E, Gambacorta MA, Scorsetti M, Ricardi U, Corvò R, Donato V, Muto P, Valentini V. Palliative radiotherapy indications during the COVID-19 pandemic and in future complex logistic settings: the NORMALITY model. Radiol Med. 2021 Dec;126(12):1619–56. https://doi.org/10.1007/s11547-021-01414-z.

Lancellotta V, Del Regno L, Di Stefani A, Fionda B, Marazzi F, Rossi E, Balducci M, Pampena R, Morganti AG, Mangoni M, Lebbe C, Garbe C, Longo C, Schinzari G, Tagliaferri L, Peris K. The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review. Radiol Med. 2022 Jul;127(7):773–83. https://doi.org/10.1007/s11547-022-01503-7.

Hewitt DB, Pawlik TM, Cloyd JM. Who will benefit? Using Radiomics to predict response to oxaliplatin-based chemotherapy in patients with colorectal liver metastases. Ann Surg Oncol. 2021 Jun;28(6):2931–3. https://doi.org/10.1245/s10434-020-09586-0.

Creasy JM, Cunanan KM, Chakraborty J, McAuliffe JC, Chou J, Gonen M, Kingham VS, Weiser MR, Balachandran VP, Drebin JA, Kingham TP, Jarnagin WR, D’Angelica MI, Do RKG, Simpson AL. Differences in Liver Parenchyma are measurable with CT Radiomics at initial Colon resection in patients that develop hepatic metastases from stage II/III Colon cancer. Ann Surg Oncol. 2021 Apr;28(4):1982–9. https://doi.org/10.1245/s10434-020-09134-w.

Hussein MAM, Cafarelli FP, Paparella MT, Rennie WJ, Guglielmi G. Phosphaturic mesenchymal tumors: radiological aspects and suggested imaging pathway. Radiol Med. 2021 Dec;126(12):1609–18. https://doi.org/10.1007/s11547-021-01412-1.

Danti G, Flammia F, Matteuzzi B, Cozzi D, Berti V, Grazzini G, Pradella S, Recchia L, Brunese L, Miele V. Gastrointestinal neuroendocrine neoplasms (GI-NENs): hot topics in morphological, functional, and prognostic imaging. Radiol Med. 2021 Dec;126(12):1497–507. https://doi.org/10.1007/s11547-021-01408-x.

Petrillo A, Fusco R, Petrillo M, Granata V, Sansone M, Avallone A, Delrio P, Pecori B, Tatangelo F, Ciliberto G. Standardized Index of Shape (SIS): a quantitative DCE-MRI parameter to discriminate responders by non-responders after neoadjuvant therapy in LARC. Eur Radiol. 2015 Jul;25(7):1935–45. https://doi.org/10.1007/s00330-014-3581-3. Epub 2015 Jan 11. PMID: 25577525.

Laurelli G, Falcone F, Gallo MS, Scala F, Losito S, Granata V, Cascella M, Greggi S. Long-Term Oncologic and Reproductive Outcomes in Young Women with Early Endometrial Cancer conservatively treated: a prospective study and literature update. Int J Gynecol Cancer. 2016 Nov;26(9):1650–7. https://doi.org/10.1097/IGC.0000000000000825.

Taghavi M, Staal F, Gomez Munoz F, Imani F, Meek DB, Simões R, Klompenhouwer LG, van der Heide UA, Beets-Tan RGH, Maas M. CT-Based Radiomics Analysis before Thermal ablation to Predict Local Tumor Progression for Colorectal Liver Metastases. Cardiovasc Intervent Radiol. 2021 Jun;44(6):913–20.

留言 (0)

沒有登入
gif